Patients who take Ozempic, Mounjaro and Wegovy are less likely to be diagnosed with anxiety or depression compared to those who don’t receive the popular diabetes and weight loss drugs, according to a new study.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
